Mirikizumab as Induction and Maintenance Therapy in Patients With Ulcerative Colitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
N. Engl. J. Med 2023 Jun 29;388(26)2444-2455, G D'Haens, M Dubinsky, T Kobayashi, PM Irving, S Howaldt, J Pokrotnieks, K Krueger, J Laskowski, X Li, T Lissoos, J Milata, N Morris, V Arora, C Milch, W Sandborn, BE SandsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.